Assessment of attitude and hesitancy toward vaccine against COVID-19 in a Pakistani population: A mix methods survey
The objective of this study was to assess the attitude and hesitancy toward vaccine against COVID-19 in a Pakistani Population. A mix-method, prospective study was conducted and adults (aged ≥18 years) residing in Pakistan were invited to participate. The questionnaire was prepared, hosted in Google...
Gespeichert in:
Veröffentlicht in: | Vacunas (Barcelona. Internet. English ed.) 2022-08, Vol.23, p.S26-S32 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The objective of this study was to assess the attitude and hesitancy toward vaccine against COVID-19 in a Pakistani Population.
A mix-method, prospective study was conducted and adults (aged ≥18 years) residing in Pakistan were invited to participate. The questionnaire was prepared, hosted in Google Forms and circulated through electronic platforms and was also available to be done in in-person. Data was compiled from 15th September to 30th November 2020.
The response rate was 80%. A total of 1003 participants were included in the final analysis. Of them, 75% completed survey questionnaire online, while remaining 25% responded in-person. The mean age of the participants was 29.62±10.47 years. The majority of participants were females; 60.9% (n=611). 57.02% (n=572) of the participants were employed at the time of survey. Overall, 70.68% (n=709) of the participants had previous experience of vaccines such as the flu vaccine Only 4.9% (n=49) participants thought that they will be seriously ill from COVID-19 within six months and 39% (n=392) participants were confident that they will get COVID-19. A total of 71.29% of the participants reported they would consider getting vaccinated once available. There was statistical association between gender and getting vaccinated (P |
---|---|
ISSN: | 2445-1460 2445-1460 |
DOI: | 10.1016/j.vacune.2022.08.003 |